The Supreme Court’s recent opinion in Thompson v. United States may have significant implications for the False Claims Act (FCA). In Thompson, the Court was tasked with interpreting 18 U.S.C. § 1014, which prohibits...more
6/25/2025
/ Anti-Kickback Statute ,
Causation ,
Controlled Substances Act ,
Enforcement Actions ,
False Claims Act (FCA) ,
False Statements ,
Government Agencies ,
Healthcare Fraud ,
Judicial Authority ,
Misleading Statements ,
SCOTUS ,
Statutory Interpretation ,
Thompson v United States ,
Whistleblowers
Whistleblower Watch is a comprehensive source for all False Claims Act (FCA) news and information. Every quarter, Cozen O’Connor will provide in-house counsel and compliance professionals with a summary of the most notable...more
6/25/2025
/ Controlled Substances Act ,
Cybersecurity ,
Department of Justice (DOJ) ,
Enforcement Actions ,
Executive Orders ,
False Claims Act (FCA) ,
Federal Contractors ,
Fixed Price Contracts ,
Government Agencies ,
Healthcare ,
Healthcare Fraud ,
Kickbacks ,
Medicare ,
Paycheck Protection Program (PPP) ,
Pharmaceutical Industry ,
SCOTUS ,
Settlement ,
Thompson v United States ,
Trump Administration ,
Whistleblowers